Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2020-05-08 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东股份减持数量超过1%暨减持数量过半的进展公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of a shareholder's reduction in holdings exceeding 1%, specifically for a shareholder holding more than 5% of shares. It details the number of shares reduced, the percentage of total shares, and compliance with relevant regulations. The document does not contain financial statements or detailed financial performance data but focuses on shareholding changes and regulatory compliance related to share reduction. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2020-05-08 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulatory rules, and future plans for the buyback. It does not contain full financial statements or comprehensive financial performance data. The document length is short (1546 characters) and focuses on the update of the share buyback activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2020-05-08 Chinese
2019年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2019 Annual General Meeting (AGM) of the company 成都市贝瑞和康基因技术股份有限公司. It details the procedures of the AGM, attendance, voting results on various proposals including the 2019 annual report, financial statements, board and supervisory reports, profit distribution plan, internal control self-evaluation report, appointment of auditors, related party transactions, and employee stock ownership plans. The document focuses on the legality and validity of the AGM procedures and voting results rather than the content of the reports themselves. The presence of detailed voting results and the focus on the AGM process and resolutions indicate this is a Declaration of Voting Results & Voting Rights Announcement. The document length (7477 characters) and content confirm it is not merely an announcement of a report publication but a detailed legal opinion on the AGM and voting outcomes.
2020-05-07 Chinese
2019年年度股东大会决议公告
AGM Information Classification · 95% confidence The document is titled as a 2019 Annual General Meeting (AGM) resolution announcement for Chengdu Berry Genomics Co., Ltd. It details the date and method of the meeting, attendance, voting results on various proposals including the 2019 annual report, financial statements, board and supervisory reports, profit distribution plan, internal control self-assessment, appointment of auditors, related party transactions, and employee stock ownership plans. It also includes legal opinions confirming the legality of the meeting and voting procedures. The content is focused on the resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is about 5637 characters, which is consistent with a detailed AGM resolution announcement. Therefore, this document fits the category of AGM Information (AGM-R).
2020-05-07 Chinese
关于召开2019年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2019 Annual General Meeting (AGM) of Chengdu Berry Genomics Co., Ltd. It includes information about the meeting date, voting procedures, agenda items to be discussed and voted on, and instructions for shareholders to participate either in person or via online voting. The document references the 2019 annual report and other related reports as agenda items but does not contain the reports themselves. The document length is 4660 characters, which is relatively short and consistent with an announcement rather than a full report. The content is focused on informing shareholders about the AGM logistics and agenda, which fits the definition of AGM Information (AGM-R).
2020-05-05 Chinese
北京市金杜律师事务所关于公司第一期员工持股计划之法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's first employee stock ownership plan (员工持股计划). It discusses the legal compliance, internal procedures, and information disclosure related to the employee stock ownership plan. The document is not a financial report, earnings release, or management discussion. It is a detailed legal opinion supporting the implementation of an employee stock ownership plan, which is a capital/financing related matter. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 8432 characters, which is substantial and contains detailed legal analysis rather than a brief announcement or certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2020-05-05 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.